BCL2 FORMULATIONS
Disclosed are pharmaceutical formulations containing the compound of Formula (I): (I) and pharmaceutically acceptable salts thereof. Methods of treating disorders, including cancer, using the formulations are also disclosed. L'invention concerne des formulations pharmaceutiques contenant le com...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PAUFF, James Michael LINDEMANN, Christopher M TRIVEDI, Ruchit Sunil HYMAN, David Michael KU, Nora Chien Yee |
| description | Disclosed are pharmaceutical formulations containing the compound of Formula (I): (I) and pharmaceutically acceptable salts thereof. Methods of treating disorders, including cancer, using the formulations are also disclosed.
L'invention concerne des formulations pharmaceutiques contenant le composé de formule (I) : (I) et des sels pharmaceutiquement acceptables de celui-ci. L'invention concerne également des méthodes de traitement de troubles, y compris du cancer, à l'aide des formulations. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023250343A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023250343A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023250343A13</originalsourceid><addsrcrecordid>eNrjZBB0cvYxUnDzD_IN9XEM8fT3C-ZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsZGpgbGJsaOhsbEqQIAkaIeng</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BCL2 FORMULATIONS</title><source>esp@cenet</source><creator>PAUFF, James Michael ; LINDEMANN, Christopher M ; TRIVEDI, Ruchit Sunil ; HYMAN, David Michael ; KU, Nora Chien Yee</creator><creatorcontrib>PAUFF, James Michael ; LINDEMANN, Christopher M ; TRIVEDI, Ruchit Sunil ; HYMAN, David Michael ; KU, Nora Chien Yee</creatorcontrib><description>Disclosed are pharmaceutical formulations containing the compound of Formula (I): (I) and pharmaceutically acceptable salts thereof. Methods of treating disorders, including cancer, using the formulations are also disclosed.
L'invention concerne des formulations pharmaceutiques contenant le composé de formule (I) : (I) et des sels pharmaceutiquement acceptables de celui-ci. L'invention concerne également des méthodes de traitement de troubles, y compris du cancer, à l'aide des formulations.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231228&DB=EPODOC&CC=WO&NR=2023250343A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231228&DB=EPODOC&CC=WO&NR=2023250343A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAUFF, James Michael</creatorcontrib><creatorcontrib>LINDEMANN, Christopher M</creatorcontrib><creatorcontrib>TRIVEDI, Ruchit Sunil</creatorcontrib><creatorcontrib>HYMAN, David Michael</creatorcontrib><creatorcontrib>KU, Nora Chien Yee</creatorcontrib><title>BCL2 FORMULATIONS</title><description>Disclosed are pharmaceutical formulations containing the compound of Formula (I): (I) and pharmaceutically acceptable salts thereof. Methods of treating disorders, including cancer, using the formulations are also disclosed.
L'invention concerne des formulations pharmaceutiques contenant le composé de formule (I) : (I) et des sels pharmaceutiquement acceptables de celui-ci. L'invention concerne également des méthodes de traitement de troubles, y compris du cancer, à l'aide des formulations.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBB0cvYxUnDzD_IN9XEM8fT3C-ZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsZGpgbGJsaOhsbEqQIAkaIeng</recordid><startdate>20231228</startdate><enddate>20231228</enddate><creator>PAUFF, James Michael</creator><creator>LINDEMANN, Christopher M</creator><creator>TRIVEDI, Ruchit Sunil</creator><creator>HYMAN, David Michael</creator><creator>KU, Nora Chien Yee</creator><scope>EVB</scope></search><sort><creationdate>20231228</creationdate><title>BCL2 FORMULATIONS</title><author>PAUFF, James Michael ; LINDEMANN, Christopher M ; TRIVEDI, Ruchit Sunil ; HYMAN, David Michael ; KU, Nora Chien Yee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023250343A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PAUFF, James Michael</creatorcontrib><creatorcontrib>LINDEMANN, Christopher M</creatorcontrib><creatorcontrib>TRIVEDI, Ruchit Sunil</creatorcontrib><creatorcontrib>HYMAN, David Michael</creatorcontrib><creatorcontrib>KU, Nora Chien Yee</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAUFF, James Michael</au><au>LINDEMANN, Christopher M</au><au>TRIVEDI, Ruchit Sunil</au><au>HYMAN, David Michael</au><au>KU, Nora Chien Yee</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BCL2 FORMULATIONS</title><date>2023-12-28</date><risdate>2023</risdate><abstract>Disclosed are pharmaceutical formulations containing the compound of Formula (I): (I) and pharmaceutically acceptable salts thereof. Methods of treating disorders, including cancer, using the formulations are also disclosed.
L'invention concerne des formulations pharmaceutiques contenant le composé de formule (I) : (I) et des sels pharmaceutiquement acceptables de celui-ci. L'invention concerne également des méthodes de traitement de troubles, y compris du cancer, à l'aide des formulations.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023250343A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | BCL2 FORMULATIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A42%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAUFF,%20James%20Michael&rft.date=2023-12-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023250343A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |